Audit of budesonide/formoterol prescribing for asthma in community pharmacy in the UK

Respiratory Medicine

Volumn 105, Issue 6, 2011, Pages 864-868

  Boyter, Anne C ^a   Ford, Naomi H ^a   Zlotos, Leon ^a,b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b The Co operative Pharmacy   (United Kingdom)

Author keywords

Asthma; Inhaled steroids; Inhalers; Prescribing

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DRUG MARKETING; HUMAN; INFORMATION PROCESSING; LICENCE; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL INFORMATION; MEDICAL RECORD; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ASTHMA; BUDESONIDE; CHILD; COST-BENEFIT ANALYSIS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; GREAT BRITAIN; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PHARMACIES; YOUNG ADULT;

EID: 79955480693     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.11.021     Document Type: Article

References (17)

1. S. Shrewsbury, S. Pyke, and M. Britton Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA) BMJ 320 7246 2000 1368 1373 (Pubitemid 30261116)
2. R.A. Pauwels, C.G. Löfdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, and P.J. Barnes Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids establishing therapy (FACET) international study group New England Journal of Medicine 337 20 1997 1405 1411
3. H.S. Nelson, S.T. Weiss, E.R. Bleecker, S.W. Yancey, P.M. Dorinsky, and SMART study group The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol Chest 129 1 2006 15 26 (Pubitemid 43265239)
4. Scottish Intercollegiate Guideline Network/British Thoracic Society British guidelines on asthma management Thorax 63 Suppl. 1 2008 issue
5. G.P. Currie, G.S. Devereux, D.K. Lee, and J.G. Ayres Recent developments in asthma management BMJ 330 7491 2005 585 589 (Pubitemid 40380355)
6. M. Palmqvist, G. Persson, L. Lazer, J. Rosenburg, P. Larsson, and J. Lötvall Inhaled dry powder formoterol and salmeterol in asthmatic patients; onset of action, duration of effect and potency European Respiratory Journal 10 1997 2484 2489 (Pubitemid 28048620)
7. J. van Noord, J.J. Smeets, J.A.M. Raaijmakers, A.M. Boomer, and F.P.V. Maesen Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of asthma European Respiratory Journal 9 1996 1684 1688 (Pubitemid 26271155)
8. A.E. Tattersfield, C.G. Löfdahl, D.S. Postma, A. Eivindson, A.G. Schreurs, and A. Rasidakis Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial Lancet 357 9252 2001 257 261 (Pubitemid 32120856)
9. M. Palmqvist, P. Arvidsson, O. Beckman, S. Peterson, and J. Lotvall Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers Pulmonary Pharmacology & Therapeutics 14 1 2001 29 34 (Pubitemid 32158294)
10. C.J. Cates, and T.J. Lasserson Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children Cochrane Database of Systematic Reviews 2 2009 10.1002/14651858.CD007313.pub2 Art. No.: CD007313
11. K.F. Rabe, E. Pizzichini, B. Ställberg, S. Romero, A.M. Balanzat, T. Atienza, and P.A. Lier Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma Chest 129 2006 246 256 (Pubitemid 43289841)
12. P. Kuna, M.J. Peters, A.I. Manjra, C. Jorup, I.P. Naya, and N.E. Martinez-Jimenez Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations International Journal of Clinical Practice 61 5 2007 725 736 (Pubitemid 46587876)
13. P.M. O'Byrne, H. Bisgaard, P.P. Godard, M. Pistolesi, M. Palmqvist, and Y. Zhu Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma American Journal of Respiratory and Critical Care Medicine 171 2005 129 136 (Pubitemid 40105411)
14. National Institute for Health and Clinical Excellence Chronic obstructive pulmonary disease - management of chronic obstructive pulmonary disease in adults in primary and secondary care 2004 CG12. London: Nice
15. AstraZenica UK Limited Summary of product characteristics symbicort turbohaler, inhalation powder 2010 http://emc.medicines.org.uk/medicine/4820/ SPC/Symbicort Turbohaler 100/6 Inhalation powder [accessed 15.02.10]
16. London New Drugs Group Evidence to support the use of symbicort SMART regime in adults with asthma APC/DTC briefing February 2008 1-10
17. World Health Organisation Chapter VII - asthma Adherence to long-term therapies - evidence for action 2003 World Health Organisation 47-59